456 related articles for article (PubMed ID: 26715266)
1. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
[TBL] [Abstract][Full Text] [Related]
2. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C
Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
6. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
[TBL] [Abstract][Full Text] [Related]
7. Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.
Avgeris M; Mavridis K; Tokas T; Stravodimos K; Fragoulis EG; Scorilas A
Carcinogenesis; 2015 May; 36(5):528-37. PubMed ID: 25804644
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer.
Su ZX; Zhao J; Rong ZH; Wu YG; Geng WM; Qin CK
Tumour Biol; 2014 Dec; 35(12):12119-25. PubMed ID: 25416437
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
10. Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer.
Blanca A; Sanchez-Gonzalez A; Requena MJ; Carrasco-Valiente J; Gomez-Gomez E; Cheng L; Cimadamore A; Montironi R; Lopez-Beltran A
APMIS; 2019 Aug; 127(8):545-553. PubMed ID: 31231851
[TBL] [Abstract][Full Text] [Related]
11. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C
Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502
[TBL] [Abstract][Full Text] [Related]
12. Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer.
Wang XL; Xie HY; Zhu CD; Zhu XF; Cao GX; Chen XH; Xu HF
Tumour Biol; 2015 Feb; 36(2):877-83. PubMed ID: 25304156
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNA profiles for bladder cancer detection.
Adam L; Wszolek MF; Liu CG; Jing W; Diao L; Zien A; Zhang JD; Jackson D; Dinney CP
Urol Oncol; 2013 Nov; 31(8):1701-8. PubMed ID: 22863868
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of miR-222 is associated with poor prognosis in bladder cancer.
Zhang DQ; Zhou CK; Jiang XW; Chen J; Shi BK
World J Surg Oncol; 2014 Jul; 12():241. PubMed ID: 25078265
[TBL] [Abstract][Full Text] [Related]
15. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
17. Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study.
Spagnuolo M; Costantini M; Ferriero M; Varmi M; Sperduti I; Regazzo G; Cicchillitti L; Díaz Méndez AB; Cigliana G; Pompeo V; Russo A; Laquintana V; Mastroianni R; Piaggio G; Anceschi U; Brassetti A; Bove A; Tuderti G; Flammia RS; Gallucci M; Simone G; Rizzo MG
J Exp Clin Cancer Res; 2020 Apr; 39(1):68. PubMed ID: 32303246
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
Scheffer AR; Holdenrieder S; Kristiansen G; von Ruecker A; Müller SC; Ellinger J
World J Urol; 2014 Apr; 32(2):353-8. PubMed ID: 23266581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
